2496
R. Venkataramanarao, V. V. Sureshbabu
LETTER
(16) (a) Thiem, J.; Wiemann, T. Angew. Chem., Int. Ed. Engl.
1990, 29, 80. (b) Ameijde, J.; Albada, H. B.; Liskamp, R. M.
J. J. Chem. Soc., Perkin Trans. 1 2002, 1042.
4.88 (t, 1 H), 5.06 (t, 1 H), 5.12 (s, 2 H), 5.27 (m, 2 H), 5.50
(br d, 1 H), 7. 33 (t, 2 H), 7.41 (t, 2 H), 7.52 (d, 2 H), 7.77 (d,
2 H). HRMS (ES): m/z calcd for C35H38N2NaO14 [M + Na]+:
733.2221; found: 733.2254.
(17) Typical Procedure for the Synthesis of Glycosylated Na-
Fmoc-Asp/Glu-5-oxazolidinones
(18) Typical Procedure for the Preparation of Glycosylated
To a solution of Fmoc-Asp/Glu-5-oxazolidinone (10 mmol)
in 10 mL of THF was added 1-amino b-glucose (10 mmol)
in THF (40 mL), HBTU (10 mmol), and DIPEA (11 mmol),
and stirred at r.t. for about 30 min. The solvent was
evaporated under reduced pressure and the residue was
diluted with H2O (15 mL) and extracted with EtOAc (3 × 20
mL). The combined organic layer was washed with 10%
citric acid (3 × 10 mL), 5% Na2CO3 solution (3 × 15 mL),
brine, and dried over anhyd Na2SO4. The solution was
concentrated and purified by column chromatography using
EtOAc–hexane (2:8).
Na-Fmoc-Asn/Gln-OH
To the glycosylated Na-Fmoc-Asn/Gln-5-oxazolidinone (10
mmol) dissolved in THF was added 1 N LiOH solution (1
equiv) and stirred at r.t. for 30 min. The reaction was
monitored by TLC. After the completion of reaction, the
reaction mixture was acidified with 10% citric acid solution
and extracted with EtOAc. The organic layer was washed
with brine and dried over anhyd Na2SO4. The solvent was
removed in vacuo, and the resulted residue was purified by
column chromatography using CHCl3, MeOH and AcOH
(40:2:1).
Selected Spectral Data
Compound 4a: white solid. IR (KBr): nmax = 1705, 1733
cm–1. 1H NMR (300 MHz, CDCl3): d = 2.03–2.13 (4 s, 12 H),
2.81 (m, 2 H), 3.80 (m, 1 H), 4.03 (t, 1 H), 4.24 (m, 2 H),
4.42–4.52 (m, 2 H), 4.98 (t, 1 H), 5.05 (t, 1 H), 5.21–5.35 (m,
2 H), 5.92 (br d, 1 H), 7. 33 (t, 2 H), 7.41 (t, 2 H), 7.52 (d, 2
H), 7.77 (d, 2 H). HRMS (ES): m/z calcd for C33H36N2NaO14
[M + Na]+: 707.2064; found: 707.2080.
Compound 4e: white solid. IR (KBr): nmax = 1698, 1732
cm–1. 1H NMR (300 MHz, CDCl3): d = 1.86 (m, 2 H), 2.03–
2.13 (4 s, 12 H), 2.22 (m, 2 H), 3.80 (m, 1 H), 4.03 (d, 1 H),
4.21–4.32 (m, 3 H), 4.48 (m, 2 H), 4.88 (t, 1 H), 5.06 (t, 1 H),
5.27 (2 H, m), 5.50 (br d, 1 H), 7. 33 (t, 2 H), 7.41 (t, 2 H),
7.52 (d, 2 H), 7.77 (d, 2 H). HRMS (ES): m/z calcd for
C34H38N2NaO14 [M + Na]+: 721.2221; found: 721.2413.
Compound Fmoc-Asn(2,3,4,6-tetra-O-acetyl-b-D-gluco-
pyranosyl)oxazolidinone (3a: n = 1): white solid. IR (KBr):
n
max = 1700, 1735, 1801 cm–1. 1H NMR (300 MHz, CDCl3):
d = 2.03–2.13 (4 s, 12 H), 2.81 (m, 2 H), 3.80 (m, 1 H), 4.03
(t, 1 H), 4.24 (m, 2 H), 4.42–4.52 (m, 2 H), 4.98 (t, 1 H), 5.05
(t, 1 H), 5.11 (s, 2 H), 5.21–5.35 (m, 2 H), 5.92 (br d, 1 H),
7. 33 (t, 2 H), 7.41 (t, 2 H), 7.52 (d, 2 H), 7.77 (d, 2 H).
HRMS (ES): m/z calcd for C34H36N2NaO14 [M + Na]+:
719.2064; found: 719.2081.
Compound Fmoc-Gln(2,3,4,6-tetra-O-acetyl-b-D-gluco-
pyranosyl)oxazolidinone (3b: n = 2): white solid. IR (KBr):
n
max = 1698, 1730, 1800 cm–1. 1H NMR (300 MHz, CDCl3):
d = 1.86 (m, 2 H), 2.03–2.13 (4 s, 12 H), 2.22 (m, 2 H), 3.80
(m, 1 H), 4.03 (d, 1 H), 4.21–4.32 (m, 3 H), 4.48 (m, 2 H),
Synlett 2007, No. 16, 2492–2496 © Thieme Stuttgart · New York